Suzhou Alphamab Co., Ltd.

This Phase 3 study is testing a drug called KN057, given as a weekly injection under the skin, to prevent bleeding in people with hemophilia A or B (with or without inhibitors). The trial will enroll 70 males aged 12 to 65 and will monitor safety and how well the drug works over …

This early-stage trial tests a drug called KN060 in 12 adults with end-stage kidney disease who are on regular hemodialysis. The goal is to see if KN060 is safe and can prevent blood clots from forming in the dialysis machine or the patient's blood vessels. Participants will rece…

This early-stage trial is testing a new drug called KN060 for people with essential hypertension (high blood pressure). Sixty adults aged 18 to 65 will receive either KN060 or a placebo by IV drip every two weeks for 12 weeks. The main goal is to see if KN060 safely lowers blood …

This early-stage trial tests a new drug called KN069 in 36 Chinese men who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. Researchers will also look at weight and waist changes over time.